Is US residence a risk factor for Alzheimer's disease?
Editorial Material 2025 en
Authors
PH
Poul Flemming Høilund‐Carlsen
AA
Abass Alavi
TC
Tommaso Costa
Abstract
1 min read
Reducing risk factors is a useful way to counteract diseases. The prevalence of Alzheimer's disease (AD) in the US is often quoted as 6.9 million out of 333 million people, or 2.1%. It is around 0.7% in the UK, 0.9% in Denmark, and worldwide the estimate is 0.5%. Alongside risk factor reduction, the Centers for Medicare and Medicaid Services could strengthen the US fight against AD by reconsidering its October 2023 decision to liberalize reimbursement of amyloid PET scans, or better yet, advise replacing these non-specific scans with FDG-PET, which shows what AD is really about: impaired regional brain function.
Poul Flemming Høilund‐Carlsen, Mona‐Elisabeth Revheim, Tommaso Costa, Kasper P. Kepp, Rudolph J. Castellani, George Perry, Abass Alavi, Jorge R. Barrio
Pasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, Annapaola Prestia, Anna Caroli, Isabella Castiglioni, Maria Carla Gilardi, Giovanni B. Frisoni, Karl Friston, John Ashburner, Daniela Perani
Zaldy S. Tan, Sudha Seshadri, Alexa S. Beiser, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia Benjamin, Rhoda Au, Douglas P. Kiel, Ramachandran S. Vasan, Philip A. Wolf
Discussion(0)
No comments yet. Be the first to comment.